Effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc analysis

被引：0
|
作者：
Michael Pfeifer
Raymond R. Townsend
Michael J. Davies
Ujjwala Vijapurkar
Jimmy Ren
机构：
[1] Janssen Scientific Affairs,Perelman School of Medicine
[2] LLC,undefined
[3] University of Pennsylvania,undefined
[4] Janssen Research & Development,undefined
[5] LLC,undefined
来源：
Cardiovascular Diabetology | / 16卷
关键词：
Canagliflozin; Sodium glucose co-transporter 2 (SGLT2) inhibitor; Type 2 diabetes; Blood pressure; Ambulatory blood pressure monitoring; Pulse pressure; Mean arterial pressure; Double product;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc analysis
    Pfeifer, Michael
    Townsend, Raymond R.
    Davies, Michael J.
    Vijapurkar, Ujjwala
    Ren, Jimmy
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [2] Bone effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus
    Blevins, Thomas C.
    Farooki, Azeez
    POSTGRADUATE MEDICINE, 2017, 129 (01) : 159 - 168
  • [3] Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus
    Rosenthal, Norm
    Meininger, Gary
    Ways, Kirk
    Polidori, David
    Desai, Mehul
    Qiu, Rong
    Alba, Maria
    Vercruysse, Frank
    Balis, Dainius
    Shaw, Wayne
    Edwards, Robert
    Bull, Scott
    Di Prospero, Nicholas
    Sha, Sue
    Rothenberg, Paul
    Canovatchel, William
    Demarest, Keith
    PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: PRIX GALIEN 2014, 2015, 1358 : 28 - 43
  • [4] The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on mineral metabolism and bone in patients with type 2 diabetes mellitus
    Alba, Maria
    Xie, John
    Fung, Albert
    Desai, Mehul
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (08) : 1375 - 1385
  • [5] Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Subjects With Type 2 Diabetes Mellitus
    Devineni, Damayanthi
    Curtin, Christopher R.
    Polidori, David
    Gutierrez, Maria J.
    Murphy, Joseph
    Rusch, Sarah
    Rothenberg, Paul L.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (06): : 601 - 610
  • [6] Genital mycotic infections with canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus: a pooled analysis of clinical studies
    Nyirjesy, Paul
    Sobel, Jack D.
    Fung, Albert
    Mayer, Cristiana
    Capuano, George
    Ways, Kirk
    Usiskin, Keith
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (06) : 1109 - 1119
  • [7] Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor
    Nyirjesy, Paul
    Zhao, Yue
    Ways, Kirk
    Usiskin, Keith
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (07) : 1173 - 1178
  • [8] Benefits/risks of sodium-glucose co-transporter 2 inhibitor canagliflozin in women for the treatment of Type 2 diabetes
    Kushner, Pamela
    WOMENS HEALTH, 2016, 12 (03) : 379 - 388
  • [9] Pharmacokinetics and Pharmacodynamics of Henagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Chinese Patients with Type 2 Diabetes Mellitus
    Xiaolan Yong
    Aidong Wen
    Xiangyang Liu
    Haiyan Liu
    Yan-Ping Liu
    Nan Li
    Tingting Hu
    Ying Chen
    Minquan Wang
    Lantian Wang
    Xiaojiao Dai
    Juan Huang
    Jia Li
    Huaqiong Shen
    Clinical Drug Investigation, 2016, 36 : 195 - 202
  • [10] Efficacy and safety of twice-daily treatment with canagliflozin, a sodium glucose co-transporter 2 inhibitor, added on to metformin monotherapy in patients with type 2 diabetes mellitus
    Qiu, Rong
    Capuano, George
    Meininger, Gary
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2014, 1 (02): : 54 - 60
12345